"With the high levels of accuracy that we have achieved in our...

"With the high levels of accuracy that we have achieved in our clinical studies to
date, the market opportunity for ResApp’s technology has grown significantly
larger today than it appeared to be when we listed nine months ago. Servicing
the telehealth industry was our original goal and this remains an enormous
opportunity, but we have since received great interest from practitioners in
emergency rooms, clinics and outpatient settings where the great majority of​

patients are treated. We have also seen telehealth growing rapidly in Europe and

Asia (including Australia)"

- Dr Tony Keating, CEO and Managing Director Resapp Health​